Literature DB >> 16378626

Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development.

Ute Süsens1, Irm Hermans-Borgmeyer, Jens Urny, H Chica Schaller.   

Abstract

By searching the human and mouse genomic databases we found two G-protein-coupled receptors, GPR139 and GPR142, with characteristic motifs of the rhodopsin family of receptors. The gene for GPR139 maps to chromosome 7F1 of mouse and 16p12.3 of human and that for GPR142 to 11E2 of mouse and 17q25.1 of human. We isolated GPR139 from a cDNA library of adult mouse brain and GPR142 from a cDNA library of brains from 15-day-old mouse embryos. GPR139 mRNA was predominantly expressed in specific areas of human and mouse brains, whereas GPR142 mRNA showed a more ubiquitous expression both in the brain and in various peripheral glands and organs. A 50% identity and a 67% homology at the amino-acid level between the two receptors and only 20-25% identity with other G-protein-coupled receptors established them as a new subbranch within the phylogenetic tree and hints at a common or similar ligand(s). Preliminary results suggest that the cognate ligand is present in brain extracts and is, most likely, a small peptide. GPR139 signal transduction in Chinese hamster ovary cells requires coupling to an inhibitory G-protein and is mediated by phospholipase C. Dimer formation may be necessary for proper function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378626     DOI: 10.1016/j.neuropharm.2005.11.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  24 in total

Review 1.  Identifying ligands at orphan GPCRs: current status using structure-based approaches.

Authors:  Tony Ngo; Irina Kufareva; James Lj Coleman; Robert M Graham; Ruben Abagyan; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

2.  High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139.

Authors:  Jia Wang; Lin-yun Zhu; Qing Liu; Morten Hentzer; Garrick Paul Smith; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

3.  Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139.

Authors:  Feng Shi; Jing Kang Shen; Danqi Chen; Karina Fog; Kenneth Thirstrup; Morten Hentzer; Jens-Jakob Karlsson; Veena Menon; Kenneth A Jones; Kelli E Smith; Garrick Smith
Journal:  ACS Med Chem Lett       Date:  2011-02-28       Impact factor: 4.345

4.  Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy Studies.

Authors:  Ming Yu; Mike Lizarzaburu; Alykhan Motani; Zice Fu; Xiaohui Du; Jiwen Jim Liu; Xianyun Jiao; SuJen Lai; Peter Fan; Angela Fu; Qingxiang Liu; Michiko Murakoshi; Futoshi Nara; Kozo Oda; Ryo Okuyama; Jeff D Reagan; Nobuaki Watanabe; Mami Yamazaki; Yumei Xiong; Ying Zhang; Run Zhuang; Daniel C-H Lin; Jonathan B Houze; Julio C Medina; Leping Li
Journal:  ACS Med Chem Lett       Date:  2013-05-01       Impact factor: 4.345

5.  The orphan receptor GPR139 signals via Gq/11 to oppose opioid effects.

Authors:  Hannah M Stoveken; Stefano Zucca; Ikuo Masuho; Brock Grill; Kirill A Martemyanov
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

6.  Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes.

Authors:  Liangqin Guo; Dann L Parker; Yi Zang; Ramzi F Sweis; Weiguo Liu; Edward C Sherer; Nicole Buist; Jenna Terebetski; Terri Kelly; Randal Bugianesi; Birgit T Priest; Karen H Dingley; Xiaofang Li; Stan Mitelman; Gino Salituro; Maria E Trujillo; Michele Pachanski; Melissa Kirkland; Mary Ann Powles; George J Eiermann; Yue Feng; Jin Shang; Andrew D Howard; Feroze Ujjainwalla; Christopher J Sinz; John S Debenham; Scott D Edmondson; Ravi P Nargund; William K Hagmann; Derun Li
Journal:  ACS Med Chem Lett       Date:  2016-10-12       Impact factor: 4.345

7.  Genetic variants associated with longitudinal changes in brain structure across the lifespan.

Authors:  Barbara Franke; Paul M Thompson; Hilleke E Hulshoff Pol; Rachel M Brouwer; Marieke Klein; Katrina L Grasby; Hugo G Schnack; Neda Jahanshad; Jalmar Teeuw; Sophia I Thomopoulos; Emma Sprooten; Carol E Franz; Nitin Gogtay; William S Kremen; Matthew S Panizzon; Loes M Olde Loohuis; Christopher D Whelan; Moji Aghajani; Clara Alloza; Dag Alnæs; Eric Artiges; Rosa Ayesa-Arriola; Gareth J Barker; Mark E Bastin; Elisabet Blok; Erlend Bøen; Isabella A Breukelaar; Joanna K Bright; Elizabeth E L Buimer; Robin Bülow; Dara M Cannon; Simone Ciufolini; Nicolas A Crossley; Christienne G Damatac; Paola Dazzan; Casper L de Mol; Sonja M C de Zwarte; Sylvane Desrivières; Covadonga M Díaz-Caneja; Nhat Trung Doan; Katharina Dohm; Juliane H Fröhner; Janik Goltermann; Antoine Grigis; Dominik Grotegerd; Laura K M Han; Mathew A Harris; Catharina A Hartman; Sarah J Heany; Walter Heindel; Dirk J Heslenfeld; Sarah Hohmann; Bernd Ittermann; Philip R Jansen; Joost Janssen; Tianye Jia; Jiyang Jiang; Christiane Jockwitz; Temmuz Karali; Daniel Keeser; Martijn G J C Koevoets; Rhoshel K Lenroot; Berend Malchow; René C W Mandl; Vicente Medel; Susanne Meinert; Catherine A Morgan; Thomas W Mühleisen; Leila Nabulsi; Nils Opel; Víctor Ortiz-García de la Foz; Bronwyn J Overs; Marie-Laure Paillère Martinot; Ronny Redlich; Tiago Reis Marques; Jonathan Repple; Gloria Roberts; Gennady V Roshchupkin; Nikita Setiaman; Elena Shumskaya; Frederike Stein; Gustavo Sudre; Shun Takahashi; Anbupalam Thalamuthu; Diana Tordesillas-Gutiérrez; Aad van der Lugt; Neeltje E M van Haren; Joanna M Wardlaw; Wei Wen; Henk-Jan Westeneng; Katharina Wittfeld; Alyssa H Zhu; Andre Zugman; Nicola J Armstrong; Gaia Bonfiglio; Janita Bralten; Shareefa Dalvie; Gail Davies; Marta Di Forti; Linda Ding; Gary Donohoe; Andreas J Forstner; Javier Gonzalez-Peñas; Joao P O F T Guimaraes; Georg Homuth; Jouke-Jan Hottenga; Maria J Knol; John B J Kwok; Stephanie Le Hellard; Karen A Mather; Yuri Milaneschi; Derek W Morris; Markus M Nöthen; Sergi Papiol; Marcella Rietschel; Marcos L Santoro; Vidar M Steen; Jason L Stein; Fabian Streit; Rick M Tankard; Alexander Teumer; Dennis van 't Ent; Dennis van der Meer; Kristel R van Eijk; Evangelos Vassos; Javier Vázquez-Bourgon; Stephanie H Witt; Hieab H H Adams; Ingrid Agartz; David Ames; Katrin Amunts; Ole A Andreassen; Celso Arango; Tobias Banaschewski; Bernhard T Baune; Sintia I Belangero; Arun L W Bokde; Dorret I Boomsma; Rodrigo A Bressan; Henry Brodaty; Jan K Buitelaar; Wiepke Cahn; Svenja Caspers; Sven Cichon; Benedicto Crespo-Facorro; Simon R Cox; Udo Dannlowski; Torbjørn Elvsåshagen; Thomas Espeseth; Peter G Falkai; Simon E Fisher; Herta Flor; Janice M Fullerton; Hugh Garavan; Penny A Gowland; Hans J Grabe; Tim Hahn; Andreas Heinz; Manon Hillegers; Jacqueline Hoare; Pieter J Hoekstra; Mohammad A Ikram; Andrea P Jackowski; Andreas Jansen; Erik G Jönsson; Rene S Kahn; Tilo Kircher; Mayuresh S Korgaonkar; Axel Krug; Herve Lemaitre; Ulrik F Malt; Jean-Luc Martinot; Colm McDonald; Philip B Mitchell; Ryan L Muetzel; Robin M Murray; Frauke Nees; Igor Nenadić; Jaap Oosterlaan; Roel A Ophoff; Pedro M Pan; Brenda W J H Penninx; Luise Poustka; Perminder S Sachdev; Giovanni A Salum; Peter R Schofield; Gunter Schumann; Philip Shaw; Kang Sim; Michael N Smolka; Dan J Stein; Julian N Trollor; Leonard H van den Berg; Jan H Veldink; Henrik Walter; Lars T Westlye; Robert Whelan; Tonya White; Margaret J Wright; Sarah E Medland
Journal:  Nat Neurosci       Date:  2022-04-05       Impact factor: 28.771

8.  The role of orphan receptor GPR139 in neuropsychiatric behavior.

Authors:  Maria Dao; Hannah M Stoveken; Yan Cao; Kirill A Martemyanov
Journal:  Neuropsychopharmacology       Date:  2021-01-21       Impact factor: 8.294

9.  A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development.

Authors:  Kevin S Jones; Alexander P Alimov; Horacio L Rilo; Ronald J Jandacek; Laura A Woollett; W Todd Penberthy
Journal:  Nutr Metab (Lond)       Date:  2008-08-27       Impact factor: 4.169

10.  Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone Toxicity.

Authors:  Kirsten Bayer Andersen; Jens Leander Johansen; Morten Hentzer; Garrick Paul Smith; Gunnar P H Dietz
Journal:  Front Cell Neurosci       Date:  2016-06-28       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.